Target intelligence / Profile preview

Necrotic tissue proteins and fibrin

Molecular classification
Extracellular matrix component, Protein complex
01

Overview

Necrotic tissue proteins, fibrin, and fibrinogen constitute the non-viable biological debris found in chronic wounds, such as pressure sores and diabetic ulcers, often manifesting as slough or eschar. Fibrin is an insoluble protein polymer derived from fibrinogen that forms a scaffold for blood clotting and early wound repair (StatPearls, 2023). However, its persistence in chronic ulcers can form fibrin cuffs that hinder oxygen diffusion and nutrient exchange, thereby stalling the healing process (PubMed, PMC1192448). Necrotic proteins result from cell death and tissue degradation, creating a pro-inflammatory environment that promotes bacterial colonization and biofilm formation (NIH, 2022). Therapeutic strategies target these components through enzymatic debridement, utilizing exogenous proteases to selectively digest the proteinaceous debris (Wounds, 2014). Agents such as collagenase or bromelain hydrolyze these denatured proteins without harming the underlying viable tissue. By removing these physical and biochemical barriers, these drugs facilitate the transition of the wound from a chronic inflammatory state to the proliferative phase of healing. This clearance also improves the efficacy of other topical treatments and reduces the risk of infection.

Other names
SloughEscharNecrotic debrisFibrinous exudateFibrin cuffWound debris
02

Mechanism of action

Enzymatic debridement through the proteolytic degradation of denatured proteins and fibrin

03

Biological functions

HemostasisExtracellular matrix organizationInflammatory response
04

Disease associations

Chronic woundVenous leg ulcerDiabetic foot ulcerPressure ulcerBurn
05

Safety considerations

Proteolysis of healthy tissueLocal irritationHypersensitivityBleeding at the wound site
06

Interacting drugs

Collagenase clostridium histolyticum

7 more in the full profile.

07

Biomarkers

Wound bed slough percentageWound surface area reductionExudate volume

Beyond the preview

Go deeper on Necrotic tissue proteins and fibrin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Necrotic tissue proteins and fibrin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call